The treatment of cerebrovascular disease with clofibrate. Final report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section.
D000787:Angina Pectoris / Q000209:etiology; D002561:Cerebrovascular Disorders / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000009:adverse effects / Q000627:therapeutic use*; D003327:Coronary Disease / Q000209:etiology; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D002546:Ischemic Attack, Transient / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology; D010919:Placebos; D014280:Triglycerides / Q000097:blood
D010919:Placebos; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate